Munir A. Rahmani

Division of Science and Mathematics, Bethune-Cookman College, Daytona Beach, FL 32114

Received 3/25/98 Accepted 3/30/98

9. REFERENCES

1. David R. Hathaway, Keith L. March, Joseph A. Lash, Leonard P. Adam, and Robert L.Wilensky: Vascular Smooth Muscle, A review of the Molecular Basis of Contractility. Circulation 83(20), 382-390 (1991)

2. R. A. Murphy, J. Herlihy, T. Jeremiah, and J. Megerman: Force-Generating Capacity and Contractile Protein Content of Arterial Smooth Muscle. J Gen Physiol Vol. 64, 691-705 (1974)

3. D. O. Levitsky, M. Clerguw, F. Lambert, M. V. Souponitskaya, T. H. Le Jemte, Y. Lecarpentier and A. M. Lompre': Sarco[lasmic Reticulum Calcium Transport and Ca²⁺-ATPase Gene Expression in Tjoracic and Abdominal Aortas of Normotensive and Spotaneously Hypertensive Rats. J B iol Chem 268(11),8325-8331, (1993)

4. G. R. Monteith, E. P. Kable, T. H. Kuo, and Roufogalis: Elevated Plasma Memebrane and Sarcoplasmic Reticulum Ca²⁺ Pump mRNA Levels in Cultured Aortic Smooth Muscles from Spontaneously Hypertensive Rats. Bico Biop R 230, 344-346, (1997)

5. C-M. Hai, R. A. Murphy: Regulation of shortening velocity by cross-bridge phosphorylation in smooth muscle. Am J Physiol 255,C86-C94, (1988)

6. C. M. Rembold, R. A. Murphy: Myoplasmic [Ca²⁺] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle. Circul Res 63,593-603, (1988)

7. F. Rioux, and B.A. Berkowitz: Role of the Thyroid Gland in the Development and Maintenance of Spontaneous Hypertension in Rats. Circul Res 40(3), 306-312 (1977)

8. R. Shibata, S. Morita, K. Nagi, S. Miyata and T. Iwasaka: Calcium dependence of ouabain-induced contraction in aortas from spontaneously hypertensive rats. Eur J harmacol 190, 147-157, (1990)

9. John A. Colwell. Aspirin Therapy in Diabetes: Diabetese Care 20(11), 1767-1771, (1997)

10. C. H. Hennekens, M. L. Dyken, and V. Fuster: Aspirin as a Therapeutic Agent in Cardiovascular Disease ( AHA Scientific Statement) Circulation 96,2751-2753, (1997)

11. E. Carafoli. Calcium Pump of the Plasma Membrane: Physiol Rev 71(1); 129-153, (1991)

12. N. Morel, N. Wibo, and T. Godfraind: A calmodulin stimulated Ca²⁺ Pump in rat aorta plasma membranes. Biochim Biophys 644,82-88, (1981)

13. Henderson, A. H. Endothelium in Control: Br Heart J 65,116-125, (1991)

14. A. D. Hughes, and M. Schachter: Hypertension and Blood Vessels. Brit Med B 50(2),356-370, (1994)

15. T. Luscher, and G. Noll: Endothelium as an end-point in interventional trials, Concepts, methods and current data. J Hypertensi14 (Suppl 2),S111-121, (1996)

16. S. M. Marchenko, and S. O. Sage: Electrical Properties of Resting and Acetylcholine Stimulated Endothelium in Intact Rat Aorta. J Physiol 462,735-751, (1993)

17. C. J. Barnes, W, E. Hardman, and I. L. Cameron: Aspirin, Age, and Proximity to Lymphoid Nodules Influence Cell Proliferation Parameters in Rat Clonic Crypts. Cell Prolif 28,59-71, (1995)

18. John, A. Baron, and Robert E. Greenberg: Could Aspirin Really Orevent Colon Cancer. N Eng J of Medi 325(23),1644-1646, (1991)

19. D.A. Cox, and M.L. Cohen: Relationship between Phospholipase D Activation and Endothelial Vasomotor Dysfunction in Rabbit Aorta. J Pharmacol ExpTher 288(1),305-311, (1997)

20. R. Davisson, J. N. Bates, A. K. Johnson, and S.J. Lewis: Use-Dependednt Loss of Acetylcholine- and Bradykinin-Mediated Vasodilation After Nitric Oxide Synthase Inhibition, Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28,354-369, (1996)

21. Keith A. Freeman, A. Mao, Leif O. Nordberg, J. Pak, and Ronald, J. Tallarida: The Relationship Between Vessel Wall Tension and the Magnitude and Frequency of Oscillation in Rat Aorta. Life Sci 56(6)-129-134, (1995)

22. L. C.Fuchs, D. Nuno, K. G.Lamping and , A. K. Johnson: Charaterization of Endothelium-Dependent Vasodilation and Vasoconstriction in Coronary Arteries From Spontaneously Hypertensive Rats. Am J Hypertens 9, 475-483 (1996)

23. H. Jahan, S. Kobayashi, J. Nishimura and , H. Kanaide: Endotheliun-1 and angiotensin II act as progression but nit competence growth factors in vascular smooth muscle cells. Eur J Pharmacol 295,261-269, (1996)

24. C. Janaskul, R.G. King and , A. L. A. Boura.: Effects of Endothelial Cell Removal on alpha_1-Adrenoceptor-Mediated Response of Aorta of Pregnant Rats. Clin Exp Ph 17,147-157, (1990)

25. C. Katnik and D. J. Adams: Characterization of ATP-sensitive potassium channels in freshly dissociated rabit aortic endothelial cells. Am. J. Physiol 272, H2507-H2511, (1997)

26. Thomas F. Luscher: Endothelin. J cardio Ph 18 (Suppl 10),S15-S22, 1991.

27. P. Nava, T. Collados, F Masso and V. Guarner: Endothelin Mediation of Insulin and Glucose-Induced Changes in Vascular Contractility. Hypertension 30,825-829, (1997)

28. M. Ohno, J. P. Cooke, V. J. Dzau and G. H. Gibbons: Fluid Shear stress Induces Endotjelial Transforming Growth Factor Beta-1 Transcription and Production. J Clin. Invest 95,1363-1369, (1995)

29. V. Richard, M. Hogie, M. Clozel, B-M. Loffler and C. T. Thuillez: In Vivo Evidence of an Endothelin-Induced Vasopressor Tone After Inhibition of Nitric Oxide Synthesis in Rats. Circulation 91,771-775, (1995)

30. E. L. Schiffrin: Endothelin, Potential Role in Hypertension and Vascular Hypertrophy, Hypertension 25,1135-1143, (1995)

31. S. Seewald, A. Sachinides, R. Dusing, Y. Ko, , C. Seul, P. Epping and H. Vetter: Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells. Atherosceler 130,121-131, (1997)

32. John T Shepherd,. and Zvonimir, S. Katusic: Endothelium-Derived Vasoactive Factor-, I, endo thelium-dependent relaxation. Hypertension 18 [Suppl III],III-76-III-85, (1991)

33. S. Suzuki, J. Kajikuri, A.Suzuki and , T. Itoh: Effects of Endothelin-1 on Endothelial Cells in the Porcine Coronary Artery. Cir Res 169,1361-1368, (1991)

34. A. Calver, J. Collier and , P. Vallance. Nitric Oxide and Cardiovascular Control. Exp Physiol 78,303-326, (1993)

35. C. F. Kung, and , T. F. Luscher: Different Mechanisms of Endothelial Dysfunction With Aging and Hypertension in Rat Aorta. Hypetension 25 194-200,(1995)

36. Arthur M. Melkumyants. Balashove, Sergey A. and Kartamyshev, Sergy P: Anticonstrictor Effect of Endothelium Sensitivity to Shear Stress. Pflugers Arc; Eur J Physiol 427,264-269, (1994)

37. S. S. Bhagwat, P. R. Hamann, W. E. Still, S. R. Bunting and , F. A. Fitzpatrick: Synthesis and Structure of Platelet Aggregation Factor Thromboxane A₂. Nature 315,511-513, (19985)

38. Zivonimir S. Katusic, and John T. Shepherd: Endothelium-Derived Vasoactive Factor,II; Endothelium-Dependent Contraction. Hypertension [Suppl. III], III-86-III-92, (1991)

39. C. R. Pace-Asciak, M. C. Carrara, G. Rangraj, and , K.C. Nicolaou: Enhance Formation of PGI₂, A Potent Hypotensive Substance, By Aortic Ring and Homogenates of the Spontaneously Hypertensive Rat. Prostaglandin 15(6),1005-1012,(1978)

40. Y. Wang, Y. Coe, O. Toyoda and , F. Coceani: Involvement of Endothelin-1 in Hypoxic Pulmonary Vasoconstriction in the Lamb. J Physiol 482(2),421-434, (1995)

41. H. Asano, K. Shimizu, , M. Muramatsu, Y. Iwama, Y. Toki, Y., Miyazaki, K. Okumura, H. Hashimoto and T. Ito: Prostaglandin H₂, as an Endothelium-Derived Contracting Factor Modulates Endotheli-1-Induced Contraction. J Hypertens 12,383-390, (1994)

42. Ikuko Sato and S. Murota: Paracrine Function of Endothelium-Derived Nitrixc Oxide. Life Sci 56(13),1079-187, (1995)

43. M. Fukao, Y. Hattori, M. Kanno, I. Sakuma and A. Kitabatake: Sources of Ca²⁺ in relation to generation of acetylcholine-induced endothelium-dependent hyperpolarization in rat mesenteric artery. Br J Pharamcol 120,1328-1334, (1997)

44. C. J. Garland, F., Plane, B. K. Kemp and T. M. Cocks: Endothelium-dependent hyperpolarization, a role in the control of vascular tone. Trens Phar 16,23-30, (1995)

45. M. Barton, F., Cosentino, Ralf P. Brandes, P. Moreau, S. Shaw and Thomas F. Luscher: Anatomic Heterogeneity of Vascular Aging, Role of Nitric Oxide and Endothelium Hypertension 30,817-824, (1997)

46. I. Fleming, B. Fisskthaler and . Busse: Calcium signaling in ednothelial cells invoves activation of tyrosin kinases and lead to activiation of mitogenic-activated protein kinases. Cir Res 76,522-529, (1995)

47. J.E. Gage, O.M. Hess, T. Murakami, M. Ritter, J. Grimm, and H.P. Krayenbuehl: Vasoconstriction of stenotic coronary arteries during dynamic excercise in patients with classic angina pectoris, reversibility by nitroglycerin. Circulation 73,865-876, (1995)

48. T. Masaki and Yanagisawa.: Physiology and Pharmacology of Endothelins. Med Res Rev 12(4),391-421, (1992)

49. G. K. Oriji and H. R. Keiser: Role of Calciuym in endothelin-induced cintraction and prostacyclin release. Prostagland (Leukotrienes and Essentail Fatty Acids) 55(6),413-417, (1996)

50. B. Battisini, P. Chailler, P. D'Orleanse-Juste, N. Briere and P. Sirois: Growth Regulatory Properteis of Endothelins. Peptides 14,385-399, (1993)

51. Karsten Schror: Antiplatelt Drugs, a comparative review. Drugs 50(1),7-28 (1995)

52. D.L. Edward, C. P. Arora, D. T. Bui and L. C. Castro: Long-term nitric oxide blockade in the pregnant rat, Effects on blood pressure and plasma levels of endothelin-1. Am J Obst G 175(2), 484-488, (1996)

53. T. Kullmer, E. Jungmann, T. Haak and K. H. Usadel: Modification of the Responses of Endothelin-1 to Exhaustive Physical Exercise Under Simulated High-Altitude Conditions With Acute Hypoxia. Metabolism 448-9, (1995)

54. H. Nakamoto, Carlose M. Ferrario, Stanley B. Fuller, David L. Robaczewski, E. Winicove and Richard H. Dean: Angiotensin-(1-7) and Nitric Oxide Interaction in Renovascular Hypertension. Hypertension 25(2),796-802, (1995)

55. Y. Takeda, I. Miyamori,T. Yoneda and R. Takeda: Increased Concentration of Endothelin Messenger RNA in the Mesenteric Arteries of Cyclosporine-Induced Hypertensive Rats. Am J Hypertens 6,427-430, (1993)

56. Felix Bochner and V. John. Loyd: Aspirin for Myocardial Infarction; Clinical Pharmacokinetic Considerations. Clin. Pharm 28(6), 433-438, (1995)

57. W. Kiowski,L. Linder and Paul Erne: Vascular Effects of Endothelin-1 and Influence of Calcium Channel Blockade. J Hypertens 12 (Suppl 1)S21-S26, (1994)

58. T. Kuga, Y. Ohara,H. Shimokawa, S. Ibayashi, H. Tomopike and A. Takeshita: Inhibitory Effects of Aspirin on Coronary Hyperreactivity to Autocoids After Arterial Balloon Injury in Miniature Pigs. J Cardio Ph 25273-281, (1995)

59. G. W. Dorenn II. and M. W. Becker: Thromboxane alpha₂ Stimulated Signal Transduction in Vascular Smooth Muscle. J Pharm Expt Ther 265(1),447-456, (1993)

60. M. Hamberg, J. Svensson and B. Samuelsson: Thromboxane, A New Group of Biologically Active Compounds Derived from Prostaglandin Endoperoxidase. Proc Natl. Acad. ci USA 72,2994-2998, (1975)

61. S. Serebryakov,S. Zakharenko,V. Snetkov and K. Takeda: Effects of Prostagalndins E1 and E2 on Cultured Smooth Muscle Cellss and Strips of Aorta. Prostagland 4(47), 353-365, (1994)

62. A. Mebazaa,R. Wetzel,M. Cherian and M. Abraham: Comparison Between Endocardial and Great Vessel Endothelial Cells, Morphology, Growth, and Prostagalndin Release. Am J Physiol 268 (Heart Circ Physiol 37) H250-H259, (1995)

63. C. Kearn and J. Hirsch: Optimal Dose for Starting and Maitaining Low-Dose Aspirin. Arch In Med 153,700-702, (1993)

64. M. Lecomte,O. Laneuville,C. Ji, David L: DeWitt and Willima L. Smith. Acetylation of Human Prostaglandin Endoperoxidase Synthase-2 (Cyclooxygenase-2) by Aspirin. J Biol Chem 269(18), 13207-13215, (1994)

65. Lenard M. Lichtenberger, C. Ulloa, Amy L. Vanous, Jim J. Romero, El;izbeth J. Dial, Paul A. Illich and Edgart T Walters: Zwitterionic Phospholipids Enhance Aspirin's Therapeutic Activity, as Demonstrated in Rodent Model Systems. J Phartm Exp Ther 277(3),1221-1227, (1996)

66. Maria I. Roson, Mariana Maquiera-Kopmann, and Ignacio, J. de la Riva: Contrasting Effects of Norepinephrine and 5-Hydroxytryptamine on Contractility of Abdominal Aorta of Two Kidney Clip Hypertensive Rats. Effects of Inhibitors of Arachidonic Acid Metabolic Enzymes. Clin Exp Hy- Theory and Practice A12(2),285-306 (1990)

67. B. J. Smith and A. L. Willis: Aspirin selctively inhibits prostagalndin production in human platelets. Nature 231, 235-237, (1971)

68. J. R. Vane: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231,232-235, (1971)

69. K. Kamata and A. Makino: A comparative study on the rat aorta and mesenteric arterial bed of the possible role of nitric oxide in the desensitization of the vasoconstrictor response to an alpha₁-adrenoceptor agonist. Br. J. Pharam 120,1221-1228, (1997)

70. N. L. Kanagy,J. R. Charpie,J. Dananberg and C. Webb: Decreased sensitivity to vasoconstrictor in aortic rings after acute exposure to nitric oxide. Am J. Physiol 271, H253-H260, (1996)

71. V. Kalpakov,D. Gordon and T. J. Kulik: Nitric Oxide-Generating Compunds Inhibit Total Protein and Collagen Synthesis in Culture Vascular Smooth Muscle cells. Cir Res 76(2), 305-309, (1995)

72. R. Busse,A. Mulsch, I. Fleming and M. Hecker: Mechanism of Nitric Oxide Release From the Vascular Endothelium. Circulation 87(suppl V),V-18-V-25, (1993)

73. H. Moritoki,H. Miyano, S. Takeuchi,M. Yamaguchi,T. Hisayama. and W. Kondoh: Endothelin-3-Induced Relaxation of Rat Thoracic Aorta, A Role for Nitric Oxide Formation. Br J Pharam 108,1125-1130, (1993)

74. Gjurmrakch Alieve, Vera Ralelvic and Geoffrey Bursstock: Depression of Endothelial nitric Oxide Symthase but Increased Expression of Endothelin-1 Immunoreactivity in Rat Thoracic Aortic Endothelium Associatee With Long-term, but Not Short-term, Sympathectomy. Circul Res 79,317-323, (1996)

75. Nigel Benjamin and John Vane: Nitric Oxide and Hypertension. Circulation 94,1197-1198, (1996)

76. A. Giaid and D. Saleh: Reduced Expression od Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension. N Engl J Med 333,,214-221, (1995)

77. Anna F. Dominiczak and David F. Bohr: Nitric Oxide and Its Putative Role in Hypertension. Hypertension 25(6), 1202-1211, (1995)

78. U. Forstermann, E. I. Closs, J. Pollock, M. Nakane, P. Schwarz, I. Gath and H. Klein: Nitric oxide synthase isozymes: characterization, purification, molecular cloning and functions. Hypertension 23, 1121-1131, (1994)

79. W. M Xu, P. Gorman, D. Sheers, G. Bates, J. Kishimoto, L. Lizhi and P. Emson: Regional localization of the gene coding for human brain nitric oxide synthase (NOS) to 12q 24.2 -24.3 by flourescent in situ hybridization. Cyto C Gen 64, 62-63, (1993)

80. W. Xu, I. Charles, S. Moncada, O. Gorman, L. Liu and P. Emson: Chromosomal assignment of inducible NOS gene and endothelial NOS gene to human chromosome 17p11-17q11 and chromosome 7, respectively. Endothelium (Supl) S24, Abstract (1993)

81. P. A. Marsden, K. T. Schappert, H. S. Chen, M. Flowers, C. L Sundell, J. N. Wilcox S. Lames, T. Michael: Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307, 287-293 (9192)

82. M. Tominaga, K. Fuji, I. Abe,Y. Takata,K. Kobayashi and M. Fujishima: Hypertension and Aging Impair Acetylcholine-Induced Vasodilation in Rats. J Hypertens 12,259-268, (1994)

83. L. Minowa, S. Miwa, S. Kobayashi, T. Enoki, X. F. Zhang, T. Komuro, Y. Iwamuro and T. Masaki: Inhibitory effect of nitrovasodialtors and cyclic GMP on ET-1-activated Ca²⁺-permeable nonselective cation channel in rat aortic smooth muscle. Br J Pharam 120,1536-1544, (1997)

84. T. Weidelt, W. Boldt and F. Markwardt: Acetylccholone-induced K+ current in smooth muscle cells of intact rat small arteries. J Physiol 500(3),617-630, (1997)

85. G.J. Dusting, P.A. Dickens, R. D'Nicolantonio and A. E. Doyle: Vascular Prostacyclin and Goldblatt hypertensive rats. Hypertension 2,31-36 (1984)

86. A. Papapetropolulos, N. Marczin, Mary D. Snead, C. Cheng, A. Milici and John D. Catravas: Smooth Muscle Cell Responsiveness to Nitrovasodilators in Hypertensive and Normotensive. Hypertension 23,476-484, (1994)

87. J. Donickier, L. Stoleru, W. Hayashida, H. V. Mechelen, P. Selvais, L. Galanti, J. P. Clozel, J. M. Ketelslegers and H. P.Puoleur: Role of Endogenous Endothelin-1 in Experimental Renal Hypertension in Dogs. Circulation 92,106-113, (1995)

88. Chu C. Chua, Roland C. Hamdy, Balvin H. L. Chua: Regulation of endothelin-1 production by thromboxane A₂ mimetic in rat heart smooth muscle cells. Biochim et Biophys Acta 1313,1-5, (1996)

89. Guy H. Neild: Endothelin Plasma Levels in Hypertensive Patients with Vascular Disease. J Hypertens 12(1),S17-S20, (1994)

90. C. Peiro, J. Redpndo, M. A. Rodriguez-Martinez, J. Angulo, J. Marin and , Carlos F. Sanchez-Ferrer: Influence of Endothellium on Cultured Vascular Smooth Mescle Cell Proliferation. Hypertension 25(2),748-751, (1995)

91. A. Dellipizzi, M.L. Pucci, A. I. Mosny, K. Deseyn and A. Nasjeltti: Contribution of Constrictor Prostanoids to the Calcium Dependent Basal Tone in the Aorta from Rats with Aortic Coarctation-Induced Hypertension, Relationship to Nitric Oxide. J Pharm Exp Ther 283,75-81, (1997)

92. Birgitta, C.P. Huskin, Maarten, G.C. Hendriks, M. Pfaffendorf,and Pieter, A. van Zwieten: Effect of Aging and Hypertension on the Reactivity of Isolated Conduit and Resistance Vessels. Microvasc R 48, 303-315, (1994)

93. J. Torok and M. Gerova': Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta. Mech Age D 95,143-152, (1997)

94. R. Rahimian, I Laher, G. Dube and C. van Breemaen: Estrogen and Selective Estrogen Receptor Modulator LY117018 Enhances Release of Nitric Oxide in Rat Aorta. J Pharm ExpTher 283,116-122, (1997)

95. K. Kauser and G. B. Rubanyi: Gender Differences in Endothelial Dysfunction in the rat Aorta of Spontaneously Hypertensive Rats. Hypertension 25,517-523, (1995)

96. Mills, John A. Aspirin, The Ageless Remedy: N Eng J Medi 325(18),1303-1304, (1991)

97. F. Bochner, A. A. Somgyo and K. M. Wilson: Bioinequivalence of For 100mg Oral Aspirin Formulations in Healthy Volunteers. Clin Pharmac 21(5),394-399, (1991)

98. N. J. Davies, M. R. Gazvani, R. G. Farquharson and S. A. Walkinshaw: Low-Dose Aspirin in the Prevention of Hypertensive Disorders of Pregnancy in Relatively Low-Risk Nulliparous Women. Hypertens P14(1), 49-55 (1995)

99. John C. Hauth, Robert L. Goldenberg, Richard C. Parker, Jr., Joseph B.Philip, Rachel L. Copper, Mary B. DiBard and Gary R. Cutter: Low-dose aspirin therapy to prevent preeclampsia. Am J Obst G168,1083-1093, (1993)

100. T.F. Imperiale, , & A. Stollenwerk-Petrulis: A Meta-analysis of low dose aspirin for the prevention of pregnancy induced hypertensive disease. JAm Med A 266,261-265, (1991)

101. K.A. Louden, Fiona A. Broughton-Pipkin, E. M. Symond, P. Tuohy, C. O'Callahan, S. Heptinstall, S. Fox and J. R. A. Mitchell: A Randomized placebo-controlled study of the effect of low dose aspirin on platelt reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. Brit J Obst G 99,371-376, (1992)

102. P. McParland, J. M. Pearce, & G. V. P. Chamberlain: Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 335,1552-1555, (1990)

103. F. Parazzini, C. Benedetto, T. Frusca, G. Gregorini, L. Bocciolone, L. Marozio and M. Romero: Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 341,396-400, (1993)

104. E. Schiff, E. Peleg, M. Goldenberg, T. Rosenthal, E. Ruppin, M. Tamarkin, G. Barkai, G. Ben-Baruch, I. Yahal, J. Blankenstein, B. Goldman & S. Mashiach: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Eng J Med 321,251-356, (1989)

105. S. Uzan, M. Beaufils, G. Breart, B. Bazin, C. Capitant and J. Paris: Prevention of fetal growth retardation with low-dose aspirin, findings of the EPREDA trial. Lancet 337(8755)1427-1431, (1991)

106. H. C. S. Wallenberg, G. A. Dekker, J. W. Makovitz & P. Rotmans: Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1,1-3, (1986)

107. Rober S. Adelstein and James R. Sellers: Effects of Calcium on Vascular Smooth Muscle Contraction. Am J Card 59, 4B-10B (1987)

108. C. Bloomstrand, J-E. Olsson,B. Nilsson, M. von Arbin, M. Britton, C-E. Elwin, C. Helmers, B. Norrving, A. Rosen, K.Samuelsson, K. Strandberg and N. G. Wahlgren: Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophjylaxis after cerebrovascular ischemic event. Lancet 338,1345-1349, (1991)

109. M. Buerk, W. Pittroff, J. Meyer and H. Darius: Aspirin therapy, Optimized platelet inhibition with different loading and maintenance doses. Am. Heart J 130,465-472, (1995)

110. C. Cimminiello and M. Milani: Diabetes mellitus and peripheral vascular disease, is aspirin effective in preventing vacular events? Diabetolog 39,1402-1404, (1996)

111. Nananda F. Col, J. Yarzebski, Joel M. GoreJoseph S. Alpert and Robert J. Goldberg: Does Aspirin Consumption Affect the Presentation or Severity of Acute Myocardial Infarction? Arch In Med 155,1386-1389, (1995)

112. J.R. Copeland, K.A. Willoughby, T. M. Tynana, S. F. Moore and E. F. Ellis: Endothelial and non endothelial cycooxygenase medaite rabbit pial arteriole dialtion by bradykinin. Am J Physiol 268 (Heart Circ. Physiol 37),H458-466, (1995)

113. Garret A. Fitzgerald, Mary Lupinetti, Susan A. Charman and Willima N. Charman: Presystemic Acetylation of Platelets by Aspirin, Reduction in Rate of Drug Delivery to Improve Biochemical Selectiveity for Thromboxane A2. J Pharm Exp Ther 259 (3), 1043-1049, 1991.

114. J. S. Floris: Epinephrine and Genesis of Hypertension, Hypertension 19,1-18, (1992)

115. Thomas Force, Richard Milani, Patricia Hibberd, Reinhard Lorenzw, Waltraud Udelhoven, Alexander Leaf and Petere Weber: Aspirin-Induced Decline in Prostacyclin Production in Patients With Coronary Artery Disease Is Due to Decreased Endoperoxide Shift. Circulation 84,2296-2293, (1991)

116. Jan, V. Gijin, A. Algra, J. Kappelle and A. van Latum: A comparison of the Two doses of Aspirin (30 mg vs. 283 mg A Day) in patients after a transient Ischemic Attack or Minor Ischemic Stroke. N Eng J Med 325(18),1261-1266, (1991)

117. Allen W. Gomoll and Martin L. Ogletree: Failure of aspirin to interfere with the cardioprotective effects of ifetroban. Eur J Pharm 271,471-479, (1994)

118. S.E., Hankinson, J. M., Seddon, G. A. Colditz, M. J. Stampfer, B. Rosner, F. E. Speizer and W. C. Willet: A Prospective study of Aspirin Use and Cataract Extraction in Women. Arc Ophth 111,503-508, (1993)

119. J. M. Herbert, A. Bernat, M. Samama and J. P. Maffrand: The Antiaggregating and Antithrombotic Activity of Ticlopidine Is Potentiated by Aspirin in the Rat. Thromb Haem 76(1),94-98, (1996)

120. T. W. Meade and G. J. Miller: Combined Use of Aspirin and Warfarin in Primary Prevention of Ischemic Hear Disease in Men at High Risk. Am J Card 75,23B-26B, (1995)

121. S. Rotondo, D. Rotilio, C. Cerletti and G. de Gaetano: Red Wine, Aspirin and Platelet Function. Thromb Haem 72(1),813-819, (1994)

122. Roger G. Thomas, H. Thibadeaux, Carol J. Erret, Martin M. Bednar, Cordell E. Gross and Wiliam F. Bennett: Intravenous Aspirin Causes a Paradoxical Attenuation of Cerebrovascular Thrombolysis. Stroke 26,1039-1046 (1995)

123. J. R. Vane and R. M. Botting. Heart Disease, Aspirin, and Fish Oil: Circulation 84(6), 2588-2590, (1991)

124. Lars C Wallentin: Aspirin (75 mg/day) After an Episode of Unstable Coronary Artery Disease, Long-Term Effects on the Risk for Myocardial Infarction, Occurence of Severee Angina and The Need for Revascularization. J Am Col C 18,1587-1593, (1991)

125. C. Watala and K. Gwozdzinski: Effect of Aspirin on Confirmation and Dynamics of Membrane Proteins in Platelets and Erythrocytes. Biochem Pharm 45(6),1343-1349, (1993)

126. Z. Dong, C. Huang, R. E. Brown and W.Y. Ma: Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin. J Biol Chem 272(15),9962-9970, (1997)

127. Michael J. Thun, Mohan M. Namboodiri and Clark W. Heath, Jr.: Aspirin Use and Reduced Risk of Fatal Colon Cancer. N Eng J Med 325 (23),1593-1596, (1991)

128. E. Kopp, and S. Ghosh: Inhibition of NF-kB by Sodium Salicylate and Aspirin. Science 265956-959, (1994)

129. J. P. Bourreau, Z.D. Zhang, A.M. Low, C.Y. Kwan and E.E. Daniel: Ryanodine and Adrenergic, Purinergic Stimulation in the Rat Vas Deferens Smooth Muscle, Functional and Radioligand Binding Studies. J Pharm Exp Ther 256(3), 1063-1071 (1991)

130. Methias W. Reipe, K. Kasischke and Anett Raupach: Acetylsalicylic Acid Increases Tolerance Against Hypoxix and Chemical Hypoxia. Stroke 28,2006-2011, (1997)

131. R. Hamid, M. Robinson and J. M. Pearce: Low dose aspirin in women with raised maternal serum alpha-fetoprotrein and abnormal Doppler waveform pattern from the uteroplacental circulation. Brit J Obst G 101, 481-484 (1994)

132. L. M. Lichtenberger: The hydrophobic barrier properties of gasterointestinal mucuc. Ann R Physl 57,565-583, (1995)

133. L. M. Lichtenberger, Z. M. Wang, M, N. Giraud, J. J. Romero and J. C. Barreto: Effect of naproxen on gastric mucosal hydrophobicity (Abstract) Gastroenty 108, A149, (1995)

134. L. M. Lichtenberger, Z. M. Wang, J. J. Romero, C. Ulloa, J. C. Perez, M, N. Giraud and J. C. Barreto: Non-steroidal and anti-inflamatory drugs (NSAID) associate with zwitterionic phospholipids, Insight into the mechanisms and reversal of NSAID-induced gastrointestinal injury. Nature Medicine 1, 154-158, (1995)

135. B. Ali and . Kaur: Mammalian tissue acetylsalicylic esterase(s), identification, distribution and discrimination from other esterases. J Pharm Exp Ther 226,594-598, 1983.

136. Marco, A. C. Benedito: Flourimetric Determination of Tissue Distribution and Differences Between the Activity of Aspirin Esterases I and II in Mice and Rats. J Pharm Pha 49,273-276, (1997)

137. P. A. Harris and S. Riegelman: Acetylsalicylic acid hydrolysis in human blood and plasma. J Pharm Sci 56,713-716, (1967)

138. L.-A. Pini, G. Vitale and M. Sandrini: Serotonine and Opiate involvement in the Antinccociceptive Effecti of Acetylsalicylic Acid. Pharmacol 54,84-91, (19967)

139. S.H. Ferreira, S. Moncada and J. R. Vane: Prostagalndins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharm 49,86-97, (1973)

140. Clark W. Heath, Michael J. Thun, E. R. Greenberg, B . Levin and Lawrence J. Marnett: Nonsteroidal Antiinflammatory Drugs and Human Cancer. Cancer 74,2885-2888, (1994)

141. M. L. Klein: Macular Degneration, Is Aspirin a Risk for Progressive Disease? j Am Med A 266(16)2279, (1991)

142. D. Conte, M. Nordio, S., Fillo, G. deGiorgio, A. Isidori and F. Romanelli : Aspirin Inhibition of Naloxone-Induced Luteinizing Hormone Secretion in Man. J Clin End 81(5),1772-1775, (1996)

143. F. Y. Li, Diane H. Russel, Stuart I. MyersNorman W. Weisbrodt and Frank G. Moody: Gallbladder Contrctility in Aspirin- and Cholestrol- Fed Prairie Dogs. Gastroent y 106, 1662-1667, (1994)

144. John V. Bosso, Lawrence B. Schwartz and Donald D. Stevenson: Tryptase and histamine release during aspirin-induced respiratory reaction. J Allerg Cl 88,830-837, (1991)

145. Neil H. Graham, Christopher J. Burrell, Robert M. Douglas, P. Debelle and L. Davis: Adverse Effects of Aspirin, Acetominophen, and Ibuprofen on Immune Function, Viral Shedding, and Clinical Status in Rhinovirus-Infected Volunteers. J Infec Dis 162,1277-1282, (1990)

146. R. E. Shakelford, P. B. Alford, Y. Xue, S.F. Thai, D. O. Adams and S. Pizzo: Aspirin Inhibits Tumor Necrosis Factor-z Gene Expression in Murine Tissue Macrophages. Molec Pharm 52,421-429, (1997)

147. W. R. WIlliams and A. Pawlowicz: Aspirin-Sensitive Asthma, Significance of the Cyclooxygenasae-Inhibiting and Protein-Binding Properties of Analgesic Drugs. Int A Al Im 95,303-308, (1991)

148. S. O'Sullivon, B. Dahlen, Sven E Dahlen and M. Kumlin: Increased urinary excretion of the prostagalndin D2metabolite 9a, 11b-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin- induced airway obstruction. J Allerg Cl 98,421-432, (1996)

149. B. McAdam, R. M. Keimowitz, M. Maher and D. J. Fitzgerald: Transdermal Modification of Platelt Function, An Aspirin Patch System Results in Marked Suspension of Platlet Cucooxygenase. J Pharm Exp Ther 277(2),559-564, (1996)

150. W. D. Steyn and H. Odendaal: Randomised controlled trial of ketanserin ans aspirin in prevention of pre-eclampsia. Lenacet 350,1267-1271, (1997)

151. G. Kwon, J. R. Hill, J. A Corbet. and M. L. McDaniel: Effects of Aspirin on Nitric Oxide Formation and De Novo Protein Synthesis by RINm5F Cells and Rat Islets. MolecPharm 52398-405, (1997)

152. Y. Merhi, J. Bernier, Y. Marois and R. Guidoin: Acute Thrombogenicity of Arterial Prostheses Exposed to Reduced Blood Flow in Dogs, Effects of Heparin, Aspirin, and Prostacyclin. J Cardio Ph 26,1-5, (1995)

153. R. R. Taylor, F. A. Gibbons, G. D. Cope, G. N. Cumpston, G. C. Mews and P. Luke: Effects of Low-Dose Aspirin After Cornary Angioplasty. Am J Card 68,874-878, (1991)

154. P. T. Larsson, N. H. Wallen and P. Hjemdahl: Norepinephrine-Induced Human Platelet Activiation iIn Vivio Is Only Partly Counteracted by Aspirin. Circulation 891951-1957, (1994)

155. E. J. Willard, R. A. Lange and D. L. Hillis: The Use of Aspirin in Ischemic Heart Disease. N Eng J Medi 327(3), 175-181, (1992)

156. Victoria L. Lamb, Annette J. Schwartz, William R. Rohn and Lana. Kaiser: Cyclooxygenase Inhibitors Depress Norepinephrine Constriction of Rat Abdominal, But Not Thoracic , Aorta. Eur J Pharm 256221-226, (1994)

157. M. A. Rahmani, T. Mangroo, M. Neves, M. Bienaime, S. Wiggins. and J. Williams: Effects of Aspirin on the Contractility of Aortic Rings in vitro from Spontaneously Hypertensive Rats. Artery 20(3),135-146, (1993)

158. M. A. Rahmani, T. Mangroo, M. Bienaime, S. Wiggins and J. Williams: Effect of Aspirin on the Contractility of Aortic Smooth Muscle in Female Spontaneously Hypertensive Rats. Artery 19 (5),271-283, (1992)

159. J. L. Mehta, P. Mehta and D. Lawson: Alterations in Platelet Alpha 2-Adrenoceptors by Aspirin. Agent Actio 24,196-203, (1988)

160. M. Grilli, M. Pizzi, M. Memo and Pier F. Spano: Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-kB Activation. Science 274,1383-1385, (1996)

161. K. Yin, Z. M. Chu and L. J. Beilin: Effect of fish oil feeding on blood pressure and Vascular Reactivity in Spontaneously Hypertensive Rats. Clin Exp Ph 17,235-239, (1990)

162. M. A. Rahmani, V. David,M. Huang and G. DeGray: Effect of Aspirin on the Contractility of Aortic Smooth Muscle and the Course of Blood Pressure Development in Male Spontaneously Hypertensive Rats. Accepted for Artery 22(6) or 23(1) (1998)

163. K. Nishimura, Ota Mikio and Ito Katsuaki: Existence of two components in the tonic contraction of rat aorta mediated by alpha₁--adrenergic activation. Br J Pharm 102,215-221 (1991)

164. P. B. Furspan, G. J. Rinaldi, K. Hoffman and D. F. Bohr: Dietary Calcium and Cell Membrane Abnormalities in Genetic Hypertension. Hypertension 13(6) Part 2, 727-730, (1989)

165. David A. McCarron: Is Calcium More Important Than Sodium in the Pathogenesis of Essential Hypertension? Hypertension. 7(4), 607-613, (1985)

166. N. Decker, J. D. Ehrhardt, G. Leclerc and J. chawrtz: Post Junctional a-Adrenoceptors, alpha₁- and alpha₂- Subtypes in Rat Vas culature in vitro and in vivo. Nuauyn-Schmiedbergs Arc Pharmacol 326,1-6, (1984)

167. M. A. Rahmani, I. R. Cheema, S. Sen and B. Peoples: Evaluation of Isomers of Octopamine for In Vitro alpha- Adrenergic Stimulation of the Aortic Smooth Muscle from Spontaneously Hypertensive Rats. Cytobios 52,7-16, (1987)

168. M. A. Rahmani, I. R. Cheema, S. Sen, B. Peoples and S. Riley, S: Effect of Hypothyroidism on alpha₁-and alpha_2-Adrenergic Responsiveness in Rat Aortic Smooth Muscle. Artery 14(6), 362-383 (1987)

169. M. A. Rahmani, M., Neves, T. Mangroo. and T. Bennett: In Vitro Caffeine Induced Aortic Smooth Muscle Reactivity In Rat. Artery 17 (3),127-143 (1990)

170. Theophile Godfraind: Classification of Calcium Antagonists. Am J Card 59,11B-23B, (1987)

171. Imad A. Alhaddad, L. Tkaczevski, F. Siddiqui, R. Mir and Edward J. Brown Jr: Aspirin Enhances the Benefits of Late Reperfusion om Infarct Shape. Circulation 91,2819-2823, 1995